Zenith Drugs Limited is a pharmaceutical company specialising in manufacturing and trading high-quality, affordable medicines, including generic drugs.
The company adheres to WHO-GMP guidelines and has received the ISO 9001:2015 certification from a respected EuroUK certification body, demonstrating its commitment to quality.
The product portfolio of the company includes :
- ORS Powder;
- Liquid Orals;
- Ointments;
- Liquid Externals; and
- Capsules
The Food & Drugs Administration has approved over 600 products, of which 325 are currently in production.
The company is in the process of setting up a new manufacturing facility in Village Muradpura, Depalpur, Indore, Madhya Pradesh.
The company supplies its products to countries such as Costa Rica in Central America and the Caribbean and Pacific regions, Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan , Cambodia in Southeast Asia, Tajikistan, Liberia, Sierra Leone, and Conakry.
Zenith Drugs Limited specializes in third-party manufacturing, also known as white label manufacturing, for esteemed pharmaceutical companies such as Ajanta Pharma, Bio Medical Laboratories, and Zest Pharma, among others.
There are currently 89 employees as of March 31, 2023 – 61 on payroll and 28 on contract.
Zenith Drugs IPO – Details
| IPO Opening Date | 19 February 2024 |
| IPO Closing Date | 22 February 2024 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 51,48,800 Shares Worth ₹40.68 Crore Fresh Issue: 51,48,800 Shares Worth ₹40.68 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹75 – ₹79 |
| Market Lot | 1600 Shares |
| Min Order | 1600 Shares (1 Lot) |
| Listing At | NSE SME |
| Register | Bigshare Services Pvt Ltd |
| QIB Shares Offered | 50% |
| NII (HNI) Shares Offered | 15% |
| Retail Shares Offered | 35% |
Zenith Drugs IPO – Date Schedule
| IPO Open Date | 19 February 2024 |
| IPO Close Date | 22 February 2024 |
| Basis of Allotment | 23 February 2024 |
| Initiation of Refund | 26 February 2024 |
| Credit of Shares to Demat Account | 26 February 2024 |
| IPO Listing Date | 27 February 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on Feb 22, 2024 |
Zenith Drugs IPO – Lots Size & Price
| Application | Lots | Shares | Amount ( Cut-Off) |
| Retail (Minimum) | 1 | 1600 | ₹1,26,400 |
| Retail (Maximum) | 1 | 1600 | ₹1,26,400 |
| HNI (Minimum) | 2 | 3200 | ₹2,52,800 |
Competitive Strengths
- Experienced Promoters and Management Team.
- Cost Efficiency.
- Formulation & Development.
- Regulatory Compliance.
- Global Reach.
- Product Portfolio.
- Supply Chain Efficiency.
- Scalable Business Model.
- Strong sales, marketing, and distribution capabilities.
Company Promoters
- Mr. Sandeep Bhardwaj
- Mr. Bhupesh Soni
- Mr. Ajay Singh Dassundi
Object Of The Issue
- Purchase of Machinery & Equipments for Setting up New Unit.
- Existing Manufacturing Block Upgradation.
- Working Capital Requirements.
- General Corporate Purposes.
Company Financial
| Particulars | Total Revenue | Total Expense | Profit After Tax | Total Borrowing |
|---|---|---|---|---|
| 31 March 2021 | 73.51 | 68.91 | 3.02 | 15.48 |
| 31 March 2022 | 92.66 | 88.26 | 3.12 | 18.80 |
| 31 March 2023 | 115.69 | 108.48 | 5.15 | 26.05 |
| 30 September 2023 | 69.48 | 61.87 | 5.39 | 29.02 |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 35.13% |
| ROCE | 37.29% |
| Debt/Equity | 1.51 |
| RoNW | 29.88% |
| P/BV | 5.5 |
| Pre IPO | Post IPO | |
| EPS (Rs) | 4.29 | 6.29 |
| P/E (x) | 18.4 | 12.56 |
Zenith Drugs IPO Promoter Holding
| Pre Issue Share Holding | 100.00% |
| Post Issue Share Holding | 69.98% |
Zenith Drugs IPO Prospectus
Company Contact Information
| Zenith Drugs Limited K. No. 72 / 5, Village Muradpura NA Depalpur, Indore-453001 Phone: +91 8435501867 Email: info@zenithdrugs.com Website: https://zenithdrugs.com/ |
Zenith Drugs IPO Registrar
| Bigshare Services Pvt Ltd Phone: +91-22-6263 8200 Email: ipo@bigshareonline.com Website: https://ipo.bigshareonline.com/ipo_status.html |
Zenith Drugs IPO Lead Manager(s)
| 1. Gretex Corporate Services Limited |
Zenith Drugs IPO FAQs
| What is Zenith Drugs IPO? Zenith Drugs IPO is a SME IPO. The issue is priced at ₹75 – ₹79 per equity share. The IPO is to be listed on NSE SME. |
| When Zenith Drugs IPO will open? The IPO is to open on 19 February 2024 for QIB – 50%, NII – 15% and Retail – 35% Investors. |
| How to Zenith Drugs IPO? You can apply Zenith Drugs IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form. |
| How to Apply the Zenith Drugs IPO through 5 Paisa? Log in to 5 Paisa Application with your credentials. Select the IPO. You will see the IPO Name “Zenith Drugs”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with 5 Paisa. |
| How to Apply the Zenith Drugs IPO through Edelweiss? Log in to Angle One Application with your credentials. Select the IPO. You will see the IPO Name “Zenith Drugs”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Edelweiss. |
| What is Zenith Drugs IPO Size? Zenith Drugs IPO size is ₹40.68 crores. |
| What is Zenith Drugs IPO Price Band? Zenith Drugs IPO Price Band is ₹75 – ₹79. |
| What is Zenith Drugs IPO Minimum and Maximum Lot Size? The minimum bid is 1600 Shares with ₹1,26,400 amount while the maximum bid is 1600 shares with ₹1,26,400. |
| What is the Zenith Drugs IPO Allotment Date? Zenith Drugs IPO allotment date is 23 February 2024. |
| What is the Zenith Drugs IPO Listing Date? Zenith Drugs IPO listing date is 27 February 2024. The IPO is to list on NSE SME. |
